Nolato AB Series B | Ownership
Companies that own Nolato AB Series B
Capital Research & Management Co. (World Investors)
1,416,026
6.01%
1,416,026
0.01%
06/28/2018
Didner & Gerge Fonder AB
1,269,222
5.39%
-751,227
1.21%
05/03/2018
Lannebo Fonder AB
1,100,000
4.67%
-550,000
1.31%
06/28/2018
Nordea Investment Management AB
776,293
3.3%
147,752
0.18%
12/31/2017
E. Öhman J :or Fonder AB
607,737
2.58%
-46,900
0.91%
12/31/2017
DNB Asset Management AS
563,578
2.39%
563,578
0.22%
12/31/2017
The Vanguard Group, Inc.
432,467
1.84%
1,696
0%
07/31/2018
Dimensional Fund Advisors LP
424,387
1.8%
-47,447
0.01%
04/30/2018
SEB Investment Management AB
420,773
1.79%
-11,130
0.08%
12/31/2017
Svolder AB (Investment Management)
347,800
1.48%
-2,200
7.31%
12/31/2017
| Address |
Nolatovägen
Torekov SN 269 04
Sweden
|
|
Employees
|
- |
| Website |
http://www.nolato.com |
| Updated |
07/08/2019 |
| Nolato AB engages in the development and manufacture of polymer product systems for customers in medical technology, telecommunications, hygiene, automotive products and other selected industrial sectors. It operates through the following segments: Medical Solutions, Integrated Solutions, and Industrial Solutions. The Medical Solutions segment develops and manufactures complex product systems and components within medical technology, as well as advanced packaging solutions for pharmaceuticals and dietary supplements. |
